Rhim, Seoul
Byung Sang Rhim, Seoul KR
Patent application number | Description | Published |
---|---|---|
20100315330 | CONTROL APPARATUS FOR COMPLEX INPUT INTERFACE - The present disclosure relates to a user input apparatus for integrated processing of user inputs via various types of switches. In one aspect, the apparatus includes: an input port connected to either an electrical switch or a mechanical switch to receive a user input signal via the electrical switch or the mechanical switch; a switch selection unit configured to store an electrical input unit activating information in case the input port is connected to the electrical switch, and to store a mechanical input unit activating information in case the input port is connected to the mechanical switch; an electrical input unit coupled to receive an electrical input signal inputted via the electrical switch, in case the electrical input unit activating information is stored in the switch selection unit; and a mechanical input unit coupled to receive a mechanical input signal inputted via the mechanical switch, in case the mechanical input unit activating information is stored in the switch selection unit. | 12-16-2010 |
20130027348 | TOUCH SENSING PANEL AND DEVICE FOR DETECTING MULTI-TOUCH SIGNAL - Provided are a touch sensing panel and a touch sensing apparatus for detecting an absolute location with respect to at least one touch, including a driving electrode forming a mutual capacitance between a sensing electrode and the driving electrode in response to a predetermined driving signal and including at least two electrode surfaces divided by a width size. | 01-31-2013 |
Chul Yun Rhim, Seoul KR
Patent application number | Description | Published |
---|---|---|
20160108041 | SUBSTITUTED PYRIDINONE COMPOUNDS AS MEK INHIBITORS - The invention provides novel substituted heterocyclic compounds represented by Formula I and Formula II, or a pharmaceutically acceptable salt, solvate, polymorph, ester, tautomer or prodrug thereof, and a composition comprising these compounds. The compounds provided can be used as inhibitors of MEK and are useful in the treatment of inflammatory diseases, cancer and other hyperproliferative diseases. The invention further provides a method of treatment for inflammatory diseases, cancer and other hyperproliferative diseases in mammals, especially humans. | 04-21-2016 |
Hyang-Suk Rhim, Seoul KR
Patent application number | Description | Published |
---|---|---|
20160114007 | COMPOSITION FOR PREVENTING OR TREATING AUTOIMMUNE DISEASE, COMPRISING, AS ACTIVE INGREDIENT, PINK1 PROTEIN OR POLYNUCLEOTIDE ENCODING SAME - The present invention relates to a composition for preventing or treating an autoimmune disease comprising, as an active ingredient, PINK1 protein or polynucleotide encoding the same. The PINK1 protein according to the present invention inhibits the activity of Th17, promotes the activity of a regulatory T cell (Treg), and increases autophagy in Treg cells, thereby controlling excessive immune responses. Therefore, the PINK1 protein can be effectively used as a pharmaceutical composition or an immunosuppressant, which is capable of preventing or treating an autoimmune disease, such as arthritis, and the like, caused by dysregulation of various kinds of immune responses. | 04-28-2016 |
Hyewhon Rhim, Seoul KR
Patent application number | Description | Published |
---|---|---|
20090325979 | NOVEL IMIDAZOLYLALKYLCARBONYL DERIVATIVES AS CALCIUM CHANNEL MODULATORS AND PREPARATION METHOD THEREOF - Disclosed are novel imidazolylalkylcarbonyl derivatives useful as calcium channel modulators and a preparation method of the same. Also disclosed is a method for the treatment of diseases by administering the above compounds based on their inhibitory activity against calcium channel. | 12-31-2009 |
20100004286 | NOVEL ISOINDOLINONE DERIVATIVES HAVING INHIBITORY ACTIVITY AGAINST T-TYPE CALCIUM CHANNEL AND METHOD FOR PREPARATION THEREOF - Disclosed are isoindolinone derivatives, represented by Chemical Formula 1, having inhibitory activity against T-type calcium channels, pharmaceutically acceptable salts thereof, a preparation method thereof, and a pharmaceutical composition comprising the same as an active ingredient. | 01-07-2010 |
20100056545 | NOVEL PHENYLACETATE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PREPARATION METHOD THEREOF AND COMPOSITION FOR PREVENTION OR TREATMENT OF DISEASES INDUCED BY ACTIVATION OF T-TYPE CALCIUM ION CHANNEL CONTAINING THE SAME AS AN ACTIVE INGREDIENT - Disclosed herein are a new phenylacetate derivative represented by Chemical Formula 1 or pharmaceutically acceptable salt thereof, a preparation method thereof, and a composition for prevention or treatment of diseases induced by the activation of T-type calcium ion channels containing the same. The composition containing the phenylacetate derivative according to the present invention effectively inhibits the activation of T-type calcium ion channels and may be useful in the prevention or treatment of diseases such as hypertension, cancer, epilepsy, and neurogenic pains induced by the activation of T-type calcium ion channels. | 03-04-2010 |
20100094006 | NOVEL PYRAZOLYLMETHYLAMINE COMPOUNDS AS CALCIUM CHANNEL MODULATORS AND PREPARATION METHOD THEREOF - The present invention relates to pyrazolylmethylamine-piperazine derivatives and their pharmaceutically acceptable salts effective as calcium channel modulators and a method of manufacturing the same. The present invention also relates to the medicinal use of the above compounds as therapeutic treatment of diseases due to their effect as calcium channel modulators. | 04-15-2010 |
Hye Whon Rhim, Seoul KR
Patent application number | Description | Published |
---|---|---|
20080293786 | NOVEL 2-IMINO-1,3-THIAZOLINE-BASED COMPOUNDS AND T-TYPE CALCIUM CHANNEL INHIBITORS CONTAINING THE SAME - Novel 2-imino-1,3-thiazoline based compounds represented by Chemical Formula I, and T-type calcium channel inhibitors containing the compound are provided. The T-type calcium channel inhibitors according to the present invention are useful as a treating agent of diseases associated with over-expression of the T-type calcium channel. | 11-27-2008 |
20080312253 | Pharmaceutical compositions containing pyrazole derivatives for treating as serotonin antagonist - The present invention relates to a pharmaceutical composition containing a pyrazole derivative as an active ingredient, which has antagonistic activity against serotonin 5-HT | 12-18-2008 |
20090054433 | PHARMACEUTICAL COMPOSITIONS CONTAINING QUINAZOLINE DERIVATIVES FOR TREATING AS SEROTONIN RECEPTOR ANTAGONIST - The present invention relates to a pharmaceutical composition containing one or more quinazoline compounds as an active ingredient, which has antagonistic activity against serotonin 5-HT | 02-26-2009 |
20100056456 | Omega Conotoxins - The present invention relates to a method for increasing the binding reversibility of a ω-conotoxin to a N-type calcium channel, which comprises preparing a ω-conotoxin having a Ile and/or Ala residue at a position of amino acid (11 and/or 12), respectively in the second loop between cysteine residues (2 and 3) of the ω-conotoxin represented by the formula I, such that the prepared ω-conotoxin has the increased binding reversibility to N-type calcium channel. In addition, the present invention relates to a novel ω-conotoxin and a pharmaceutical composition having plausible properties in view of blocking activity to and specificity to N-type calcium channel, and dramatically improved binding reversibility to N-type calcium channel. | 03-04-2010 |
20110319456 | BENZOARYLUREIDO COMPOUNDS, AND COMPOSITION FOR PREVENTION OR TREATMENT OF NEURODEGENERATIVE BRAIN DISEASE CONTAINING THE SAME - Novel benzoarylureido compounds and a use thereof for prevention and/or treatment of the neurodegenerative brain disease are provided. The neurodegenerative brain diseases may include Alzheimer's disease, dementia, Parkinson's disease, stroke, amyloidosis, Pick's disease, Lou Gehrig's disease, Huntington's disease, Creutzfeld-Jakob disease, and the like. | 12-29-2011 |
Hyun-Chul Rhim, Seoul KR
Patent application number | Description | Published |
---|---|---|
20120303015 | ELECTRODE NEEDLE AND HEMOSTATIC DEVICE INCLUDING THE SAME - An electrode needle includes an electrode needle body, a metal tube, and an outer insulating tube. The electrode needle body is connected to a positive electrode of an RF generator. The metal tube is fixed around the electrode needle body and insulated from the electrode needle body. The metal tube is connected to a negative electrode of the RF generator. The outer insulating tube surrounds an upper part of the metal tube to expose a lower part of the metal tube. The outer insulating tube is movable longitudinally along the electrode needle body to vary an exposed area of the metal tube. At least one of a position, an area, and a cauterization speed of a site to be cauterized is controlled by varying the exposed area of the metal tube. | 11-29-2012 |
Ji Heon Rhim, Seoul KR
Patent application number | Description | Published |
---|---|---|
20110124607 | COMPOSITION FOR REGULATION CELLULAR SENESCENCE COMPRISING LYSOPHOSPHATIDIC ACID AND INHIBITOR OF ADENYLYL CYCLASE AS ACTIVE INGREDIENTS - The present invention relates to the molecular mechanism inducing cell proliferation in aged human fibroblasts by inhibiting AMPK using LPA and AC inhibitor. Particularly, the present invention relates to a composition comprising LPA and ACI as active ingredients and the invention proves with the said composition that LPA and ACI regulate different phosphorylation of AMPKα and thus inactivate p53 and induce senescent cell proliferation. This results support the fact that AMPK signal transduction plays an important role in cell proliferation of senescent cells. | 05-26-2011 |
20120083472 | PHARMACEUTICAL COMPOSITION FOR PROMOTING THE HEALING OF WOUNDS AND CONTAINING LYSOPHOSPHATIDIC ACID AND AN ADENYLYL CYCLASE INHIBITOR AS ACTIVE INGREDIENTS - The present invention relates to a pharmaceutical composition for promoting the healing of wounds, containing lysophosphatidic acid and an adenylyl cyclase inhibitor as active ingredients, and more particularly, to a pharmaceutical composition which contains an adenylyl cyclase inhibitor and which promotes the healing of wounds in senescent cells or aged persons having physiological characteristics different than those of young cells or young persons. In addition, the present invention relates to a method for promoting the healing of wounds involving treating a wounded person with an effective dose of the lysophosphatidic acid and adenylyl cyclase inhibitor. | 04-05-2012 |
Sang-Woo Rhim, Seoul KR
Patent application number | Description | Published |
---|---|---|
20090201925 | Apparatus and method for setting routing path between routers in chip - An apparatus and a method for setting a routing path in System-on-a-Chip (SoC) having an n×n net topology-based structure comprising a plurality of intellectual properties (IPs), each with a unique address, and a plurality of switches forming one-to-one correspondence to the IPs, to transmit and receive data between the IPs by using at least one of the switches. Accordingly, an orthogonal code having orthogonality is assigned according to the direction of transmission of each data (that is, output port). Then, an output port where the data is transmitted is determined, and the data is spread based on an orthogonal code assigned to the output ports of the at least one of the switches. | 08-13-2009 |
20110069770 | Method of Data Modulation and Demodulation in SoC - A method of modulating data, which is represented by two data types of ‘high’ and ‘low’, and demodulating the modulated data, is disclosed. In a method of data modulation and demodulation for a communication system which has a transmitting end modulating a data and a receiving end demodulating the transmitted data from the transmitting end, the data is represented by two types including ‘high’ and ‘low’, and the receiving end receives at least one data which consists of at least one code-word spread by a unique orthogonal code. The receiving end adds up the received data in the unit of code-word, and subtracts the length of the orthogonal code from a value which is obtained by doubling the sum of the code-word, when the code-word of the orthogonal code is ‘0’. The receiving end then averages the result after the subtraction in the unit of orthogonal code length and extracts the result, and therefore, obtains the data from the transmitting end. | 03-24-2011 |
Yoonchul Rhim, Seoul KR
Patent application number | Description | Published |
---|---|---|
20110239237 | OPTICAL DISC DRIVE - An optical disc drive is disclosed. The optical disc drive comprises a housing including an upper housing and a lower housing; and a herringbone pattern that is protruded toward the inner space of the housing on the inner surface of the upper housing and causes an air flow generated by the rotation of an optical disc to be switched to the direction of the optical disc. The herringbone pattern comprises at least one inflection point, and makes an acute angle at the inflection point relative to the direction of the air flow formed along the inner surface of the upper housing. Accordingly, the optical disc can be stably chucked and rotated by switching the air flow generated by the rotation of the optical disc to the direction of the optical disc. | 09-29-2011 |